Clinical Trials Browser

Phase 1/2 × Terminated × Temozolomide × Clear all

NCT02942264 2026-02-23

Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma

Phase 1/2 Terminated

53 enrolled 22 charts

Astrocytoma, Brain Neoplasms, Glioblastoma, Recurrence, Gliosarcoma

NCT04421378 2024-12-16

A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma

Phase 1/2 Terminated

74 enrolled 23 charts

Glioblastoma

NCT01505608 2024-08-06

Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma

Phase 1/2 Terminated

14 enrolled 11 charts

Neuroblastoma

NCT03190967 2023-10-11

T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic Radiosurgery

Phase 1/2 Terminated

12 enrolled 16 charts

Brain Neoplasms, Breast Neoplasms

NCT00667953 2023-03-30

Study of Temzolomide and Gleevec in Advanced Melanoma

Phase 1/2 Terminated

32 enrolled 8 charts

Melanoma

NCT04851834 2022-12-20

NTX-301 Monotherapy in Advanced Solid Tumours and in Combination With Platinum-based Chemotherapy in Advanced Ovarian & Bladder Cancer and in Combination With Temozolomide in High-grade Glioma

Phase 1/2 Terminated

CNSGenitourinaryGynecologic

Urinary Bladder Neoplasms, Glioma, Ovarian Neoplasms

NCT03119064 2022-12-13

329

Phase 1/2 Terminated

12 enrolled 13 charts

Glioblastoma

NCT01110876 2021-08-25

Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)

Phase 1/2 Terminated

21 enrolled 8 charts

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

NCT02046187 2021-06-16

Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma

Phase 1/2 Terminated

Brain Neoplasms, Glioblastoma, Glioma

NCT00961844 2021-02-26

Trial for Vaccine Therapy With Dendritic Cells in Patients With Metastatic Malignant Melanoma

Phase 1/2 Terminated

Melanoma

NCT01590082 2020-09-02

Doxycycline, Temozolomide and Ipilimumab in Melanoma

Phase 1/2 Terminated

12 enrolled 6 charts

Melanoma

NCT01601184 2019-05-21

Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Patients With Medulloblastomas With an Activation of the Sonic Hedgehog Pathway

Phase 1/2 Terminated

Microphthalmia, Isolated, with Coloboma 5, Medulloblastoma

NCT01044966 2019-02-12

A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma

Phase 1/2 Terminated

12 enrolled 12 charts

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

NCT00925132 2017-07-02

Treatment of Resistant Metastatic Melanoma Using Decitabine, Temozolomide and Panobinostat

Phase 1/2 Terminated

39 enrolled 8 charts

Melanoma, Neoplasm Metastasis

NCT00724841 2016-07-22

A Phase I/II Study of GMX1777 in Combination With Temozolomide for the Treatment of Metastatic Melanoma

Phase 1/2 Terminated

Melanoma

NCT00376103 2009-09-18

Radiation Boost for Newly Diagnosed Glioblastoma Multiforme

Phase 1/2 Terminated

Brain Neoplasms, Glioblastoma

NCT00304200 2009-02-05

Temodar and Sutent as Therapy for Melanoma

Phase 1/2 Terminated

Melanoma